https://phys.org/news/2024-04-antibiotic-scientists-ai-sleeper-bacteria.html Phys.org Topics * Week's top * Latest news * Unread news * Subscribe [ ] Science X Account [ ] [ ] [*] Remember me Sign In Click here to sign in with or Forget Password? Not a member? Sign up Learn more * Nanotechnology * Physics * Earth * Astronomy & Space * Chemistry * Biology * Other Sciences * Medical Xpress Medicine * Tech Xplore Technology [INS::INS] * * share this! * 47 * Twit * Share * Email 1. Home 2. Biology 3. Cell & Microbiology 1. Home 2. Biology 3. Biotechnology * * * --------------------------------------------------------------------- April 8, 2024 Editors' notes This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility: fact-checked peer-reviewed publication trusted source proofread When an antibiotic fails: Scientists are using AI to target 'sleeper' bacteria by Alex Ouyang, Massachusetts Institute of Technology When an antibiotic fails: Scientists are using AI to target 'sleeper' bacteria Still from a time-lapse microscopy video of E. coli cells treated with semapimod in the presence of SYTOX Blue. Credit: Massachusetts Institute of Technology Since the 1970s, modern antibiotic discovery has been experiencing a lull. Now the World Health Organization has declared the antimicrobial resistance crisis as one of the top 10 global public health threats. When an infection is treated repeatedly, clinicians run the risk of bacteria becoming resistant to the antibiotics. But why would an infection return after proper antibiotic treatment? One well-documented possibility is that the bacteria are becoming metabolically inert, escaping detection of traditional antibiotics that only respond to metabolic activity. When the danger has passed, the bacteria return to life and the infection reappears. "Resistance is happening more over time, and recurring infections are due to this dormancy," says Jackie Valeri, a former MIT-Takeda Fellow (centered within the MIT Abdul Latif Jameel Clinic for Machine Learning in Health) who recently earned her Ph.D. in biological engineering from the Collins Lab. Valeri is the first author of a recent paper published in Cell Chemical Biology that demonstrates how machine learning could help screen compounds that are lethal to dormant bacteria. Tales of bacterial "sleeper-like" resilience are hardly news to the scientific community--ancient bacterial strains dating back to 100 million years ago have been discovered in recent years alive in an energy-saving state on the seafloor of the Pacific Ocean. [INS::INS] MIT Jameel Clinic's Life Sciences faculty lead James J. Collins, a Termeer Professor of Medical Engineering and Science in MIT's Institute for Medical Engineering and Science and Department of Biological Engineering, recently made headlines for using AI to discover a new class of antibiotics, which is part of the group's larger mission to use AI to dramatically expand the existing antibiotics available. According to a paper published by The Lancet, in 2019, 1.27 million deaths could have been prevented had the infections been susceptible to drugs, and one of many challenges researchers are up against is finding antibiotics that are able to target metabolically dormant bacteria. Still from a time-lapse microscopy video of E. coli cells treated with semapimod in the presence of SYTOX Blue. Credit: Massachusetts Institute of Technology In this case, researchers in the Collins Lab employed AI to speed up the process of finding antibiotic properties in known drug compounds. With millions of molecules, the process can take years, but researchers were able to identify a compound called semapimod over a weekend, thanks to AI's ability to perform high-throughput screening. Semapimod is an anti-inflammatory drug typically used for Crohn's disease, and researchers discovered that it was also effective against stationary-phase Escherichia coli and Acinetobacter baumannii. Another revelation was semapimod's ability to disrupt the membranes of so-called "gram-negative" bacteria, which are known for their high intrinsic resistance to antibiotics due to their thicker, less-penetrable outer membrane. Examples of gram-negative bacteria include E. coli, A. baumannii, Salmonella, and Pseudomonis, all of which are challenging to find new antibiotics for. "One of the ways we figured out the mechanism of sema [sic] was that its structure was really big, and it reminded us of other things that target the outer membrane," Valeri explains. "When you start working with a lot of small molecules ... to our eyes, it's a pretty unique structure." By disrupting a component of the outer membrane, semapimod sensitizes Gram-negative bacteria to drugs that are typically only active against gram-positive bacteria. Valeri recalls a quote from a 2013 paper published in Trends Biotechnology: "For Gram-positive infections, we need better drugs, but for Gram-negative infections we need any drugs." More information: Erica J. Zheng et al, Discovery of antibiotics that selectively kill metabolically dormant bacteria, Cell Chemical Biology (2023). DOI: 10.1016/j.chembiol.2023.10.026 Journal information: Cell Chemical Biology , The Lancet Provided by Massachusetts Institute of Technology This story is republished courtesy of MIT News (web.mit.edu/ newsoffice/), a popular site that covers news about MIT research, innovation and teaching. Citation: When an antibiotic fails: Scientists are using AI to target 'sleeper' bacteria (2024, April 8) retrieved 13 April 2024 from https://phys.org/news/ 2024-04-antibiotic-scientists-ai-sleeper-bacteria.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only. --------------------------------------------------------------------- Explore further Study shows that antibiotics targeting the same enzyme elicit varied responses --------------------------------------------------------------------- 48 shares * Facebook * Twitter * Email Feedback to editors * Featured * Last Comments * Popular The experimental demonstration of a verifiable blind quantum computing protocol 9 hours ago 0 A machine learning-based approach to discover nanocomposite films for biodegradable plastic alternatives 9 hours ago 0 Saturday Citations: Listening to bird dreams, securing qubits, imagining impossible billiards 10 hours ago 0 New tidal stellar stream discovered with Gaia Apr 12, 2024 0 Team finds evidence of commonly conducted ritualized human sacrifice across Europe in the Stone Age Apr 11, 2024 0 --------------------------------------------------------------------- [gif] The experimental demonstration of a verifiable blind quantum computing protocol 9 hours ago [gif] A machine learning-based approach to discover nanocomposite films for biodegradable plastic alternatives 9 hours ago [gif] Saturday Citations: Listening to bird dreams, securing qubits, imagining impossible billiards 10 hours ago [gif] Physicists solve puzzle about ancient galaxy found by Webb telescope 12 hours ago [gif] Researchers study effects of solvation and ion valency on metallopolymers 12 hours ago [gif] Chemists devise easier new method for making a common type of building block for drugs 12 hours ago [gif] Research team discovers more than 50 potentially new deep-sea species in one of the most unexplored areas of the planet Apr 12, 2024 [gif] New study details how starving cells hijack protein transport stations Apr 12, 2024 [gif] New species of ant found pottering under the Pilbara named after Voldemort Apr 12, 2024 [gif] Searching for new asymmetry between matter and antimatter Apr 12, 2024 --------------------------------------------------------------------- Relevant PhysicsForums posts Is this egg-laying or something else? 16 hours ago Color Recognition: What we see vs animals with a larger color range Apr 12, 2024 How to Implement Beamforming in Ultrasound Diffraction Tomography Apr 10, 2024 Potentially fatal dog parasite found in the Colorado River Apr 9, 2024 What do large moles on the body indicate? Mar 30, 2024 Avian flu - A new study led by a team from the University of Maryland Mar 27, 2024 More from Biology and Medical --------------------------------------------------------------------- [INS::INS] * Related Stories [gif] Study shows that antibiotics targeting the same enzyme elicit varied responses Mar 15, 2024 [gif] New antibiotic class effective against multidrug-resistant bacteria discovered Apr 1, 2024 [gif] Dozens of potential new antibiotics discovered with free online app Nov 18, 2019 [gif] Status update in evolutionary race between humans and resistant bacteria: Two steps forward for us Jan 17, 2024 [gif] New drug candidate fights off more than 300 drug-resistant bacteria Aug 10, 2022 [gif] Antibiotics with novel mechanism of action discovered Oct 23, 2019 * Recommended for you [gif] New study details how starving cells hijack protein transport stations Apr 12, 2024 [gif] Decoding the language of cells: Profiling the proteins behind cellular organelle communication Apr 12, 2024 [gif] Microbial food as a food production strategy of the future Apr 12, 2024 [gif] New CRISPR tool orchestrates antiviral defense within cells Apr 12, 2024 [gif] Scientists produce in vitro model of cell differentiation during early facial development Apr 12, 2024 [gif] Scientists discover first nitrogen-fixing organelle Apr 11, 2024 Load comments (0) Let us know if there is a problem with our content Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use our contact form. For general feedback, use the public comments section below (please adhere to guidelines). Please select the most appropriate category to facilitate processing of your request [-- please select one -- ] [ ] [ ] [ ] [ ] [ ] Your message to the editors [ ] Your email (only if you want to be contacted back) [ ] Send Feedback Thank you for taking time to provide your feedback to the editors. Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages. E-mail the story When an antibiotic fails: Scientists are using AI to target 'sleeper' bacteria Your friend's email [ ] Your email [ ] [ ] I would like to subscribe to Science X Newsletter. Learn more Your name [ ] Note Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Phys.org in any form. [ ] [ ] [ ] [ ] [ ] [ ] [ ] Your message [ ] Send Newsletter sign up Get weekly and/or daily updates delivered to your inbox. You can unsubscribe at any time and we'll never share your details to third parties. [ ] Subscribe More information Privacy policy Donate and enjoy an ad-free experience We keep our content available to everyone. Consider supporting Science X's mission by getting a premium account. Remove ads Maybe later Medical Xpress Medical Xpress Medical research advances and health news Tech Xplore Tech Xplore The latest engineering, electronics and technology advances Science X Science X The most comprehensive sci-tech news coverage on the web Newsletters [ ] Subscribe Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox Follow us * * * * * Top * Home * Search * Mobile version * Help * FAQ * About * Contact * Science X Account * Premium Account * Archive * News wire * Android app * iOS app * RSS feeds * Push notification (c) Phys.org 2003 - 2024 powered by Science X Network Privacy policy Terms of use E-mail newsletter [ ] Subscribe Follow us * * * * It appears that you are currently using Ad Blocking software. What are the consequences? x Quantcast